Insulin resistance characterizes glucose uptake in skeletal muscle but not in the heart in NIDDM

被引:103
作者
Utriainen, T
Takala, T
Luotolahti, M
Ronnemaa, T
Laine, H
Ruotsalainen, U
Haaparanta, M
Nuutila, P
Yki-Järvinen, H
机构
[1] Univ Helsinki, Dept Med, Div Endocrinol & Diabetol, FIN-00290 Helsinki, Finland
[2] Univ Turku, Turke PET Ctr, Turku, Finland
[3] Univ Turku, Dept Clin Physiol, Turku, Finland
[4] Univ Turku, Dept Med, Turku, Finland
[5] Univ Turku, Radiopharmaceut Chem Lab, Turku, Finland
基金
芬兰科学院;
关键词
myocardium; insulin resistance; non-insulin-dependent diabetes mellitus; positron emission tomography;
D O I
10.1007/s001250050946
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Skeletal muscle insulin resistance and coronary heart disease (CHD) often precede non-insulin-dependent diabetes mellitus (NIDDM). A recent study showed the myocardium of patients with CHD to be insulin resistant, independent of blood flow. We determined whether myocardial insulin resistance is a feature of NIDDM patients with no CHD. Skeletal muscle and myocardial glucose uptake were determined in 10 patients with NIDDM and 9 age- and weight-matched normal men of similar age and body mass index men using [F-18]-2-fluoro-2-deoxy-D-glucose and positron emission tomography under normoglycaemic hyperinsulinaemic conditions. Whole body glucose uptake, as determined by the euglycaemic clamp technique, was significantly lower in the patients with NIDDM (35+/-3 mu mol/kg body weight.min) than the normal subjects (45 +/- 3 mu mol/kg body weight.min, p < 0.02). Insulin-stimulated femoral muscle glucose uptake was significantly lower in the patients with NIDDM (71 +/- 6 mu mol/kg muscle.min) than in the normal subjects (96 +/- 5 mu mol/kg muscle.min, p < 0.01). Whole body glucose uptake was correlated with femoral muscle glucose uptake in the entire group (r = 0.76, p < 0.001), in patients with NIDDM and in normal subjects. Rates of insulin-stimulated myocardial glucose uptake were comparable between the patients with NIDDM (814+/-76 mu mol/kg muscle.min) and the normal subjects (731+/-63 mu mol/kg muscle.min, p>0.4). Whole body or femoral muscle, and myocardial glucose uptake were not correlated in all subjects, patients with NIDDM or normal subjects. We conclude that insulin resistance of the myocardium is not a feature of uncomplicated NIDDM.
引用
收藏
页码:555 / 559
页数:5
相关论文
共 32 条
[21]   DIFFERENT ALTERATIONS IN THE INSULIN-STIMULATED GLUCOSE-UPTAKE IN THE ATHLETES HEART AND SKELETAL-MUSCLE [J].
NUUTILA, P ;
KNUUTI, MJ ;
HEINONEN, OJ ;
RUOTSALAINEN, U ;
TERAS, M ;
BERGMAN, J ;
SOLIN, O ;
YKIJARVINEN, H ;
VOIPIOPULKKI, LM ;
WEGELIUS, U ;
KOIVISTO, VA .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (05) :2267-2274
[22]   INSULIN RESISTANCE AND HYPERINSULINEMIA IN PATIENTS WITH CHRONIC CONGESTIVE-HEART-FAILURE [J].
PAOLISSO, G ;
DERIU, S ;
MARRAZZO, G ;
VERZA, M ;
VARRICCHIO, M ;
DONOFRIO, F .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1991, 40 (09) :972-977
[23]   Cardiac and skeletal muscle insulin resistance in patients with coronary heart disease - A study with positron emission tomography [J].
Paternostro, G ;
Camici, PG ;
Lammerstma, AA ;
Marinho, N ;
Baliga, RR ;
Kooner, JS ;
Radda, GK ;
Ferrannini, E .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (09) :2094-2099
[24]  
Pyorala K, 1979, Diabetes Care, V2, P131, DOI 10.2337/diacare.2.2.131
[25]  
RATIB O, 1982, J NUCL MED, V23, P577
[26]   C-II PALMITATE FOR THE NON-INVASIVE EVALUATION OF REGIONAL MYOCARDIAL FATTY-ACID METABOLISM WITH POSITRON COMPUTED-TOMOGRAPHY .3. INVIVO DEMONSTRATION OF THE EFFECTS OF SUBSTRATE AVAILABILITY ON MYOCARDIAL-METABOLISM [J].
SCHELBERT, HR ;
HENZE, E ;
SCHON, HR ;
KEEN, R ;
HANSEN, H ;
SELIN, C ;
HUANG, SC ;
BARRIO, JR ;
PHELPS, ME .
AMERICAN HEART JOURNAL, 1983, 105 (03) :492-504
[27]  
SCHEUER J, 1993, CIRCULATION, V87, P54
[28]   PLASMA NOREPINEPHRINE IN CONGESTIVE HEART-FAILURE [J].
THOMAS, JA ;
MARKS, BH .
AMERICAN JOURNAL OF CARDIOLOGY, 1978, 41 (02) :233-243
[29]   IMPAIRED INSULIN-INDUCED PLATELET ANTIAGGREGATING EFFECT IN OBESITY AND IN OBESE NIDDM PATIENTS [J].
TROVATI, M ;
MULARONI, EM ;
BURZACCA, S ;
PONZIANI, MC ;
MASSUCCO, P .
DIABETES, 1995, 44 (11) :1318-1322
[30]  
VOIPIOPULKKI LM, 1993, J NUCL MED, V34, P2064